Thanks for emailing that article!
GRF-funded Catalyst For A Cure principal investigator Alfredo Dubra, PhD (Medical College of Wisconsin) has received a major grant from the National Eye Institute to develop "Platform Technologies for Microscopic Retinal Imaging" as part of the NEI's "audacious goal of restoring vision to the blind."
With collaborators at several research institutions, Dr. Dubra with co-investigator Joseph Carroll, PhD from the Medical College of Wisconsin, Milwaukee, will develop a suite of core technologies that will advance and increase the usability of next-generation retinal cameras.
The suite of new imaging technologies will include real-time eye motion stabilization, image resolution doubling, a tunable lens to improve the focusing of all colors of light, and high-throughput methods for testing the function of individual cells.
Catalyst for a Cure (CFC) is a unique approach to research developed by Glaucoma Research Foundation (GRF) to accelerate the pace of discovery toward a cure. It involves bringing together scientists from different backgrounds to work collaboratively to understand glaucoma and find ways to improve treatment and ultimately cure this blinding disease.
Last reviewed on October 29, 2017